Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Abstract: Atrial fibrillation (AF) has been reported in up to 16% of patients taking ibrutinib. Data regarding the management of AF in this patient population are limited, and stroke prevention poses a challenge because of increased risk of bleeding with ibrutinib treatment. Our study sought to desc...

ver descrição completa

Detalhes bibliográficos
Principais autores: Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2017-09-01
coleção:Blood Advances
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2473952920303153

Internet

http://www.sciencedirect.com/science/article/pii/S2473952920303153

Registros relacionados